
Important Information for the Vasculitis Community Regarding TAVNEOS® (avacopan)
Official Statement Important Information for the Vasculitis Community Regarding TAVNEOS® (avacopan) Updated Drug Safety Communication March 31, 2026 On Tuesday, March 31, 2026, the FDA







